Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

about

Mfh-val2

P1343

Q54905393-7D71FA2F-6C03-4920-9706-715DA6999CD3

P1343

Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Item

http://www.wikidata.org/entity/Q38698137

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Characterization of the new hu ...... TP53-null cell line mfh-val2.

@en

type

Item

label

Characterization of the new hu ...... TP53-null cell line mfh-val2.

@en

prefLabel

Characterization of the new hu ...... TP53-null cell line mfh-val2.

@en

P1476

Characterization of the new hu ...... TP53-null cell line mfh-val2.

@en

P2093

Concha López-Ginés

http://www.w3.org/2001/XMLSchema#string

Javier Megías

http://www.w3.org/2001/XMLSchema#string

Miguel Cerdá-Nicolás

http://www.w3.org/2001/XMLSchema#string

Robert C Callaghan

http://www.w3.org/2001/XMLSchema#string

Rosario Gil-Benso

http://www.w3.org/2001/XMLSchema#string

P2860

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activity

Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy

Tumor suppression by Ink4a-Arf: progress and puzzles

Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation

Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.

Malignant fibrous histiocytoma of the extremity.

Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.

Malignant fibrous histiocytoma: between the past and the present.

P2888

s10616-017-0112-5

P304

539-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10616-017-0112-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P4510

Mfh-val2

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sandra Pinto

Teresa San Miguel

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090350283

http://www.w3.org/2001/XMLSchema#string

P698

28676915

http://www.w3.org/2001/XMLSchema#string

P921

cell line

P932

5507838

http://www.w3.org/2001/XMLSchema#string

Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

about

P1343

P1343

Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P4510

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P4510

P478

P50

P577

P6179

P698

P921

P932